Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese…

Overview of attention for article published in International Journal of Hematology, September 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 1 X post from an account with 7,211 followers.

GVHD prophylaxis including bortezomib for allo-SCT #bmtsm https://t.co/sNcELHQ5FS https://t.co/DdZGHNPpzn

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.